Compare $NVAX vs $VCEL | Chartloom

Compare

$NVAX vs $VCEL

Novavax Inc · Vericel Corp

NVAX

Novavax Inc

VCEL

Vericel Corp

Compare $NVAX vs $VCEL

Comparing Novavax Inc and Vericel Corp

NVAXNovavax Inc

VCELVericel Corp

NVAXNovavax Inc

Market cap

$2.10B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

10.28x

Rev growth (TTM)

-61.6%

YTD performance

78.8%

52W performance

43.3%

FCF yield

-2.0%

VCELVericel Corp

Market cap

$2.05B

P/E (TTM)

86.61x

Forward P/E (NTM)

55.49x

Forward P/S (NTM)

5.56x

Rev growth (TTM)

23.0%

YTD performance

12.6%

52W performance

17.5%

FCF yield

3.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

NVAX

VCEL

Detailed metrics comparison

NVAX

Novavax Inc

VCEL

Vericel Corp

Market Cap

NVAX$2.10B

VCEL$2.05B

Enterprise Value

NVAX$2.20B

VCEL$1.92B

Price

NVAX$12.75

VCEL$40.10

P/E Ratio

NVAXN/A

VCEL86.61x

P/S Ratio

NVAX5.07x

VCEL6.69x

EV/Sales

NVAX5.32x

VCEL6.28x

EV/EBITDA

NVAX4.05x

VCEL58.45x

P/B Ratio

NVAX45.86x

VCEL5.56x

P/FCF Ratio

NVAXN/A

VCEL33.21x

EV/FCF

NVAX-51.40x

VCEL31.19x

PEG Ratio

NVAXN/A

VCEL0.32x

Forward P/E (NTM)

NVAXN/A

VCEL55.49x

Forward P/S (NTM)

NVAX10.28x

VCEL5.56x

Revenue (TTM)

NVAX$414M

VCEL$306M

Revenue Growth (YoY)

NVAX-61.6%

VCEL23.0%

Forward Rev Growth

NVAX-25.1%

VCEL16.9%

Gross Margin (TTM)

NVAX79.2%

VCEL74.6%

Operating Margin (TTM)

NVAX0.0%

VCEL6.0%

EBITDA Margin (TTM)

NVAX-24.0%

VCEL10.2%

Net Margin (TTM)

NVAX-59.9%

VCEL7.9%

FCF Margin (TTM)

NVAX-10.4%

VCEL20.1%

Net Income (TTM)

NVAX$-248M

VCEL$24M

FCF (TTM)

NVAX$-43M

VCEL$62M

EPS (TTM)

NVAX-$1.51

VCEL$0.46

ROE (TTM)

NVAX283.1%

VCEL6.9%

ROA (TTM)

NVAX-2275.0%

VCEL5.0%

ROIC (TTM)

NVAX40.0%

VCEL6.9%

Cash

NVAX$191M

VCEL$125M

Debt

NVAX$297M

VCEL$596K

Net Cash/Debt

NVAX$-106M

VCEL$125M

Current Ratio (TTM)

NVAX2.33x

VCEL5.04x

Quick Ratio (TTM)

NVAX2.23x

VCEL4.69x

Debt/Equity (TTM)

NVAX6.07x

VCEL0.00x

Debt/Assets (TTM)

NVAX0.0%

VCEL0.0%

Interest Coverage (TTM)

NVAXN/A

VCELN/A

Net Debt/EBITDA (TTM)

NVAX0.00x

VCEL0.00x

Beta

NVAX2.81

VCEL1.06

52W Performance

NVAX43.3%

VCEL17.5%

YTD Performance

NVAX78.8%

VCEL12.6%

% from 52W High

NVAX-4.7%

VCEL-18.7%

% from 52W Low

NVAX105.6%

VCEL38.5%

Asset Turnover (TTM)

NVAX0.38x

VCEL0.63x

FCF Yield (TTM)

NVAX-2.0%

VCEL3.0%

Earnings Yield (TTM)

NVAX-11.8%

VCEL1.2%

Dividend Yield (TTM)

NVAXN/A

VCELN/A

Rule of 40

NVAX-72.0

VCEL43.1

EV/GP/RG

NVAXN/A

VCEL0.39

Ticker research

View NVAX research View VCEL research

Metric	NVAX Novavax Inc	VCEL Vericel Corp
Market & Valuation
Market Cap	$2.10B	$2.05B
Enterprise Value	$2.20B	$1.92B
Price	$12.75	$40.10
P/E Ratio	N/A	86.61x
P/S Ratio	5.07x	6.69x
EV/Sales	5.32x	6.28x
EV/EBITDA	4.05x	58.45x
P/B Ratio	45.86x	5.56x
P/FCF Ratio	N/A	33.21x
EV/FCF	-51.40x	31.19x
PEG Ratio	N/A	0.32x
Forward P/E (NTM)	N/A	55.49x
Forward P/S (NTM)	10.28x	5.56x
Revenue & Growth
Revenue (TTM)	$414M	$306M
Revenue Growth (YoY)	-61.6%	23.0%
Forward Rev Growth	-25.1%	16.9%
Profitability
Gross Margin (TTM)	79.2%	74.6%
Operating Margin (TTM)	0.0%	6.0%
EBITDA Margin (TTM)	-24.0%	10.2%
Net Margin (TTM)	-59.9%	7.9%
FCF Margin (TTM)	-10.4%	20.1%
Net Income (TTM)	$-248M	$24M
FCF (TTM)	$-43M	$62M
EPS (TTM)	-$1.51	$0.46
ROE (TTM)	283.1%	6.9%
ROA (TTM)	-2275.0%	5.0%
ROIC (TTM)	40.0%	6.9%
Financial Health
Cash	$191M	$125M
Debt	$297M	$596K
Net Cash/Debt	$-106M	$125M
Current Ratio (TTM)	2.33x	5.04x
Quick Ratio (TTM)	2.23x	4.69x
Debt/Equity (TTM)	6.07x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.81	1.06
52W Performance	43.3%	17.5%
YTD Performance	78.8%	12.6%
% from 52W High	-4.7%	-18.7%
% from 52W Low	105.6%	38.5%
Efficiency & Yields
Asset Turnover (TTM)	0.38x	0.63x
FCF Yield (TTM)	-2.0%	3.0%
Earnings Yield (TTM)	-11.8%	1.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-72.0	43.1
EV/GP/RG	N/A	0.39
Ticker research	View NVAX research	View VCEL research

Valuation

P/E Ratio

VCEL

86.61x

P/S Ratio

NVAX

5.07x

VCEL

6.69x

EV/FCF

NVAX

-51.40x

VCEL

31.19x

Growth & revenue

Revenue Growth TTM

VCEL

23.0%

NVAX

-61.6%

Forward Revenue Growth

VCEL

16.9%

NVAX

-25.1%

Profitability & performance

Gross Margin

NVAX

79.2%

VCEL

74.6%

ROE

NVAX

283.1%

VCEL

6.9%

FCF Yield %

VCEL

3.0%

NVAX

-2.0%

52-Week Performance

NVAX

43.3%

VCEL

17.5%

Detailed metrics comparison

NVAX

Novavax Inc

VCEL

Vericel Corp

Market Cap

NVAX$2.10B

VCEL$2.05B

Enterprise Value

NVAX$2.20B

VCEL$1.92B

Price

NVAX$12.75

VCEL$40.10

P/E Ratio

NVAXN/A

VCEL86.61x

P/S Ratio

NVAX5.07x

VCEL6.69x

EV/Sales

NVAX5.32x

VCEL6.28x

EV/EBITDA

NVAX4.05x

VCEL58.45x

P/B Ratio

NVAX45.86x

VCEL5.56x

P/FCF Ratio

NVAXN/A

VCEL33.21x

EV/FCF

NVAX-51.40x

VCEL31.19x

PEG Ratio

NVAXN/A

VCEL0.32x

Forward P/E (NTM)

NVAXN/A

VCEL55.49x

Forward P/S (NTM)

NVAX10.28x

VCEL5.56x

Revenue (TTM)

NVAX$414M

VCEL$306M

Revenue Growth (YoY)

NVAX-61.6%

VCEL23.0%

Forward Rev Growth

NVAX-25.1%

VCEL16.9%

Gross Margin (TTM)

NVAX79.2%

VCEL74.6%

Operating Margin (TTM)

NVAX0.0%

VCEL6.0%

EBITDA Margin (TTM)

NVAX-24.0%

VCEL10.2%

Net Margin (TTM)

NVAX-59.9%

VCEL7.9%

FCF Margin (TTM)

NVAX-10.4%

VCEL20.1%

Net Income (TTM)

NVAX$-248M

VCEL$24M

FCF (TTM)

NVAX$-43M

VCEL$62M

EPS (TTM)

NVAX-$1.51

VCEL$0.46

ROE (TTM)

NVAX283.1%

VCEL6.9%

ROA (TTM)

NVAX-2275.0%

VCEL5.0%

ROIC (TTM)

NVAX40.0%

VCEL6.9%

Cash

NVAX$191M

VCEL$125M

Debt

NVAX$297M

VCEL$596K

Net Cash/Debt

NVAX$-106M

VCEL$125M

Current Ratio (TTM)

NVAX2.33x

VCEL5.04x

Quick Ratio (TTM)

NVAX2.23x

VCEL4.69x

Debt/Equity (TTM)

NVAX6.07x

VCEL0.00x

Debt/Assets (TTM)

NVAX0.0%

VCEL0.0%

Interest Coverage (TTM)

NVAXN/A

VCELN/A

Net Debt/EBITDA (TTM)

NVAX0.00x

VCEL0.00x

Beta

NVAX2.81

VCEL1.06

52W Performance

NVAX43.3%

VCEL17.5%

YTD Performance

NVAX78.8%

VCEL12.6%

% from 52W High

NVAX-4.7%

VCEL-18.7%

% from 52W Low

NVAX105.6%

VCEL38.5%

Asset Turnover (TTM)

NVAX0.38x

VCEL0.63x

FCF Yield (TTM)

NVAX-2.0%

VCEL3.0%

Earnings Yield (TTM)

NVAX-11.8%

VCEL1.2%

Dividend Yield (TTM)

NVAXN/A

VCELN/A

Rule of 40

NVAX-72.0

VCEL43.1

EV/GP/RG

NVAXN/A

VCEL0.39

Ticker research

View NVAX research View VCEL research

Metric	NVAX Novavax Inc	VCEL Vericel Corp
Market & Valuation
Market Cap	$2.10B	$2.05B
Enterprise Value	$2.20B	$1.92B
Price	$12.75	$40.10
P/E Ratio	N/A	86.61x
P/S Ratio	5.07x	6.69x
EV/Sales	5.32x	6.28x
EV/EBITDA	4.05x	58.45x
P/B Ratio	45.86x	5.56x
P/FCF Ratio	N/A	33.21x
EV/FCF	-51.40x	31.19x
PEG Ratio	N/A	0.32x
Forward P/E (NTM)	N/A	55.49x
Forward P/S (NTM)	10.28x	5.56x
Revenue & Growth
Revenue (TTM)	$414M	$306M
Revenue Growth (YoY)	-61.6%	23.0%
Forward Rev Growth	-25.1%	16.9%
Profitability
Gross Margin (TTM)	79.2%	74.6%
Operating Margin (TTM)	0.0%	6.0%
EBITDA Margin (TTM)	-24.0%	10.2%
Net Margin (TTM)	-59.9%	7.9%
FCF Margin (TTM)	-10.4%	20.1%
Net Income (TTM)	$-248M	$24M
FCF (TTM)	$-43M	$62M
EPS (TTM)	-$1.51	$0.46
ROE (TTM)	283.1%	6.9%
ROA (TTM)	-2275.0%	5.0%
ROIC (TTM)	40.0%	6.9%
Financial Health
Cash	$191M	$125M
Debt	$297M	$596K
Net Cash/Debt	$-106M	$125M
Current Ratio (TTM)	2.33x	5.04x
Quick Ratio (TTM)	2.23x	4.69x
Debt/Equity (TTM)	6.07x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.81	1.06
52W Performance	43.3%	17.5%
YTD Performance	78.8%	12.6%
% from 52W High	-4.7%	-18.7%
% from 52W Low	105.6%	38.5%
Efficiency & Yields
Asset Turnover (TTM)	0.38x	0.63x
FCF Yield (TTM)	-2.0%	3.0%
Earnings Yield (TTM)	-11.8%	1.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-72.0	43.1
EV/GP/RG	N/A	0.39
Ticker research	View NVAX research	View VCEL research